Caxton Corporation’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-3,671
Closed -$340K 20
2015
Q1
$340K Buy
+3,671
New +$340K 0.41% 8